These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23482400)

  • 1. CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.
    Hyeon J; Ahn S; Park CK
    Korean J Pathol; 2013 Feb; 47(1):9-15. PubMed ID: 23482400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy.
    Ahn S; Hyeon J; Park CK
    Gut Liver; 2013 Mar; 7(2):206-12. PubMed ID: 23560157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.
    Su FR; Ding JH; Bo L; Liu XG
    Exp Ther Med; 2014 Dec; 8(6):1745-1750. PubMed ID: 25371726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
    Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
    J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
    Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
    Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
    Ha SY; Song DH; Hwang SH; Cho SY; Park CK
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.
    Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
    Korean J Pathol; 2013 Apr; 47(2):130-6. PubMed ID: 23667372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.
    Bang H; Ha SY; Hwang SH; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):844-52. PubMed ID: 25687862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma.
    Liu ZH; Zhang Q; Ding YJ; Ren YH; Yang HP; Xi Q; Cheng YN; Miao GL; Liu HK; Li CX; Yan WQ; Li Y; Xue Z; Zhang L; Li XY; Zhao CL; Da Y; Wu XZ; Chen JQ; Zhang R; Li ZG
    Oncotarget; 2017 Sep; 8(43):74178-74187. PubMed ID: 29088777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
    Liu M; Chen L; Ma NF; Chow RK; Li Y; Song Y; Chan TH; Fang S; Yang X; Xi S; Jiang L; Li Y; Zeng TT; Li Y; Yuan YF; Guan XY
    Hepatology; 2016 May; 63(5):1544-59. PubMed ID: 27100146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma.
    Hua J; Li S; Huang C
    Oncol Lett; 2018 Sep; 16(3):2989-2994. PubMed ID: 30127888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.
    He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF
    BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
    Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
    Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.